Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: results from the EVOLUTION European registry

Autor: C.T.M. Caris, Luis Martínez-Piñeiro, Nikita R. Bhatt, A. De La Taille, Andrea Tubaro, Niall F. Davis, Wim P.J. Witjes, Mark Speakman, Anders Bjartell, Anup Patel
Rok vydání: 2021
Předmět:
Zdroj: World Journal of Urology, 39, 7, pp. 2661-2667
World Journal of Urology, 39, 2661-2667
ISSN: 0724-4983
Popis: Item does not contain fulltext Background To use the European Association of Urology Research Foundation (EAURF) registry data to determine the proportion of contemporary Lower Urinary Tract Symptoms associated with Benign Prostatic Enlargement (LUTS/BPE) patients prescribed phytotherapy, and to determine their subjective quality of life and clinical progression responses. Methods This was a prospective multicenter multinational observational registry study, conducted over 2 years. Men >= 50 years seeking LUTS/BPE were divided at baseline into two cohorts, presently/recently untreated patients (PUP) commencing pharmacotherapy at baseline and presently/recently treated patients (c-PTP) continuing previously received pharmacotherapy, with 24-month follow-up (FU). Results Overall, 2175 patients were enrolled with 1838 analyzed. Of the PUP cohort (n = 575), 92 (16%) received phytotherapy and 65 (71%,n = 65/92) completed 24-month FU, with France prescribing 34% (n = 30/89) the highest proportion of phytotherapy among all LUTS/BPE medications. In the c-PTP group (n = 1263), only 69 (5%) patients were using phytotherapy, falling ton = 35/69 (51%) at 24-month FU (highest in France 20% (n = 43/210)). Though defined disease progression occurred in
Databáze: OpenAIRE
Externí odkaz: